Pierre Dillard

Pierre Dillard has a diverse work experience spanning multiple companies and industries. Pierre is currently employed at Nykode Therapeutics as a Principal Scientist and Project Leader since March 2021. Prior to this, Pierre worked at Oslo University Hospital from February 2019 to December 2020, where they held the position of Project Leader. In this role, they were responsible for managing the partnership between the hospital and companies for the development and manufacturing of allogenic therapeutic solutions. Pierre successfully completed pre-clinical studies for the Rad-4 TCR and was involved in multiple publications, conferences, and grant applications. Pierre also has experience as a Research Scientist at Oslo University Hospital from January 2017 to February 2019. Here, they conducted research in the field of immunology and academic-industrial collaboration. Pierre has a strong publication and conference record during their time at Oslo University Hospital.

Before joining Oslo University Hospital, Pierre worked as a Post-doctoral Researcher at CNRS - Centre national de la recherche scientifique from January 2015 to October 2016. Their work involved the development of synthetic surfaces for a diagnosis method for immune diseases and the implementation of super-resolution microscopy techniques. Pierre has a significant publication and conference record in the field of biophysics and immunology. Additionally, they have prior experience as a Research Scholar at New England Biolabs and as an Intern at Biozentrum, University of Basel. In these roles, Pierre gained skills in genetic engineering, synthetic biology, and fungal culture. Pierre also had a short interim role at Anett in 2007. Overall, Pierre has a strong scientific and research background with expertise in immunology, biophysics, microscopy, academic-industrial collaboration, and management.

Pierre Dillard has an extensive education history. Pierre obtained a Bachelor's degree in Biotechnology from the ESBS in 2011, specializing in Synthetic Biology. Following this, they pursued a Master's degree in Biotechnology at both Karlsruhe Institute of Technology (KIT) and the University of Strasbourg between 2010 and 2011. Subsequently, they enrolled at Aix-Marseille University, where they completed their PhD in Biophysics & Immunology from 2011 to 2014.

In addition to their formal education, Pierre also obtained a certification in FELASA C from the NMBU School of Veterinary Science in July 2017.